trending Market Intelligence /marketintelligence/en/news-insights/trending/3d7tdqx1KsezZCqzR6ZBcQ2 content esgSubNav
In This List

Quidel's antepartum diagnostic test gets US FDA clearance

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Quidel's antepartum diagnostic test gets US FDA clearance

The U.S. Food and Drug Administration granted 510(k) clearance to Quidel Corp.'s Solana GBS Assay test, which detects Group B streptococcus in women nearing childbirth.

The bacteria can cause infections leading to sepsis, pneumonia and meningitis in newborns. Deafness and developmental disabilities may also result from the transmission Group B streptococcus at delivery.